1 Market Overview

1.1 Implantable Drug-Eluting Devices Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Implantable Drug Infusion Pumps

1.2.3 Intraocular Drug-Eluting Devices

1.2.4 Contraceptive Drug-Eluting Devices

1.2.5 Drug-Eluting Stents

1.2.6 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Diabetes

1.3.3 Contraception

1.3.4 HIV/AIDS Prevention

1.3.5 Chronic Pain Management

1.3.6 Cardiovascular

1.3.7 Ophthalmology

1.3.8 Oncology

1.3.9 Others

1.4 Global Implantable Drug-Eluting Devices Market Size & Forecast

1.4.1 Global Implantable Drug-Eluting Devices Sales in Value (2016-2026))

1.4.2 Global Implantable Drug-Eluting Devices Sales in Volume (2016-2026)

1.4.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)

1.5 Global Implantable Drug-Eluting Devices Production Capacity Analysis

1.5.1 Global Implantable Drug-Eluting Devices Total Production Capacity (2016-2026)

1.5.2 Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Implantable Drug-Eluting Devices Market Drivers

1.6.2 Implantable Drug-Eluting Devices Market Restraints

1.6.3 Implantable Drug-Eluting Devices Trends Analysis

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Implantable Drug-Eluting Devices Product and Services

2.1.4 Pfizer Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Medtronic

2.2.1 Medtronic Details

2.2.2 Medtronic Major Business

2.2.3 Medtronic Implantable Drug-Eluting Devices Product and Services

2.2.4 Medtronic Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Merck

2.3.1 Merck Details

2.3.2 Merck Major Business

2.3.3 Merck Implantable Drug-Eluting Devices Product and Services

2.3.4 Merck Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Bayer AG

2.4.1 Bayer AG Details

2.4.2 Bayer AG Major Business

2.4.3 Bayer AG Implantable Drug-Eluting Devices Product and Services

2.4.4 Bayer AG Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Product and Services

2.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Abbott

2.6.1 Abbott Details

2.6.2 Abbott Major Business

2.6.3 Abbott Implantable Drug-Eluting Devices Product and Services

2.6.4 Abbott Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Surmodics

2.7.1 Surmodics Details

2.7.2 Surmodics Major Business

2.7.3 Surmodics Implantable Drug-Eluting Devices Product and Services

2.7.4 Surmodics Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Boston Scientific Corporation

2.8.1 Boston Scientific Corporation Details

2.8.2 Boston Scientific Corporation Major Business

2.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services

2.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Titan Pharmaceuticals, Inc.

2.9.1 Titan Pharmaceuticals, Inc. Details

2.9.2 Titan Pharmaceuticals, Inc. Major Business

2.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services

2.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 BIOTRONIK

2.10.1 BIOTRONIK Details

2.10.2 BIOTRONIK Major Business

2.10.3 BIOTRONIK Implantable Drug-Eluting Devices Product and Services

2.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Allergan

2.11.1 Allergan Details

2.11.2 Allergan Major Business

2.11.3 Allergan Implantable Drug-Eluting Devices Product and Services

2.11.4 Allergan Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Bausch & Lomb

2.12.1 Bausch & Lomb Details

2.12.2 Bausch & Lomb Major Business

2.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Product and Services

2.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 REVA Medical

2.13.1 REVA Medical Details

2.13.2 REVA Medical Major Business

2.13.3 REVA Medical Implantable Drug-Eluting Devices Product and Services

2.13.4 REVA Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 MicroPort Medical

2.14.1 MicroPort Medical Details

2.14.2 MicroPort Medical Major Business

2.14.3 MicroPort Medical Implantable Drug-Eluting Devices Product and Services

2.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Implantable Drug-Eluting Devices Sales by Manufacturer

3.1 Global Implantable Drug-Eluting Devices Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Implantable Drug-Eluting Devices

3.4 Market Concentration Rate

3.4.1 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share

3.4.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share

3.5 Global Implantable Drug-Eluting Devices Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Implantable Drug-Eluting Devices Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Implantable Drug-Eluting Devices Market Size by Region

4.1.1 Global Implantable Drug-Eluting Devices Sales in Volume by Region (2016-2026)

4.1.2 Global Implantable Drug-Eluting Devices Revenue by Region (2016-2026)

4.2 North America Implantable Drug-Eluting Devices Revenue (2016-2026)

4.3 Europe Implantable Drug-Eluting Devices Revenue (2016-2026)

4.4 Asia-Pacific Implantable Drug-Eluting Devices Revenue (2016-2026)

4.5 South America Implantable Drug-Eluting Devices Revenue (2016-2026)

4.6 Middle East and Africa Implantable Drug-Eluting Devices Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Implantable Drug-Eluting Devices Sales in Volume by Type (2016-2026)

5.2 Global Implantable Drug-Eluting Devices Revenue by Type (2016-2026)

5.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Implantable Drug-Eluting Devices Sales in Volume by Application (2016-2026)

6.2 Global Implantable Drug-Eluting Devices Revenue by Application (2016-2026)

6.3 Global Implantable Drug-Eluting Devices Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Implantable Drug-Eluting Devices Sales by Type (2016-2026)

7.2 North America Implantable Drug-Eluting Devices Sales by Application (2016-2026)

7.3 North America Implantable Drug-Eluting Devices Market Size by Country

7.3.1 North America Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)

7.3.2 North America Implantable Drug-Eluting Devices Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Implantable Drug-Eluting Devices Sales by Type (2016-2026)

8.2 Europe Implantable Drug-Eluting Devices Sales by Application (2016-2026)

8.3 Europe Implantable Drug-Eluting Devices Market Size by Country

8.3.1 Europe Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)

8.3.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2016-2026)

9.2 Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2016-2026)

9.3 Asia-Pacific Implantable Drug-Eluting Devices Market Size by Region

9.3.1 Asia-Pacific Implantable Drug-Eluting Devices Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Implantable Drug-Eluting Devices Sales by Type (2016-2026)

10.2 South America Implantable Drug-Eluting Devices Sales by Application (2016-2026)

10.3 South America Implantable Drug-Eluting Devices Market Size by Country

10.3.1 South America Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)

10.3.2 South America Implantable Drug-Eluting Devices Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2016-2026)

11.2 Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2016-2026)

11.3 Middle East & Africa Implantable Drug-Eluting Devices Market Size by Country

11.3.1 Middle East & Africa Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Implantable Drug-Eluting Devices Typical Distributors

12.3 Implantable Drug-Eluting Devices Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Implantable Drug-Eluting Devices Revenue by Type, (USD Million), 2021-2026

Table 2. Global Implantable Drug-Eluting Devices Revenue by Application, (USD Million), 2021-2026

Table 3. Pfizer Basic Information, Manufacturing Base and Competitors

Table 4. Pfizer Major Business

Table 5. Pfizer Implantable Drug-Eluting Devices Product and Services

Table 6. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Medtronic Basic Information, Manufacturing Base and Competitors

Table 8. Medtronic Major Business

Table 9. Medtronic Implantable Drug-Eluting Devices Product and Services

Table 10. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Merck Basic Information, Manufacturing Base and Competitors

Table 12. Merck Major Business

Table 13. Merck Implantable Drug-Eluting Devices Product and Services

Table 14. Merck Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Bayer AG Basic Information, Manufacturing Base and Competitors

Table 16. Bayer AG Major Business

Table 17. Bayer AG Implantable Drug-Eluting Devices Product and Services

Table 18. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table 20. Johnson & Johnson Major Business

Table 21. Johnson & Johnson Implantable Drug-Eluting Devices Product and Services

Table 22. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Abbott Basic Information, Manufacturing Base and Competitors

Table 24. Abbott Major Business

Table 25. Abbott Implantable Drug-Eluting Devices Product and Services

Table 26. Abbott Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Surmodics Basic Information, Manufacturing Base and Competitors

Table 28. Surmodics Major Business

Table 29. Surmodics Implantable Drug-Eluting Devices Product and Services

Table 30. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors

Table 32. Boston Scientific Corporation Major Business

Table 33. Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services

Table 34. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Titan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors

Table 36. Titan Pharmaceuticals, Inc. Major Business

Table 37. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services

Table 38. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. BIOTRONIK Basic Information, Manufacturing Base and Competitors

Table 40. BIOTRONIK Major Business

Table 41. BIOTRONIK Implantable Drug-Eluting Devices Product and Services

Table 42. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Allergan Basic Information, Manufacturing Base and Competitors

Table 44. Allergan Major Business

Table 45. Allergan Implantable Drug-Eluting Devices Product and Services

Table 46. Allergan Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Bausch & Lomb Basic Information, Manufacturing Base and Competitors

Table 48. Bausch & Lomb Major Business

Table 49. Bausch & Lomb Implantable Drug-Eluting Devices Product and Services

Table 50. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. REVA Medical Basic Information, Manufacturing Base and Competitors

Table 52. REVA Medical Major Business

Table 53. REVA Medical Implantable Drug-Eluting Devices Product and Services

Table 54. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. MicroPort Medical Basic Information, Manufacturing Base and Competitors

Table 56. MicroPort Medical Major Business

Table 57. MicroPort Medical Implantable Drug-Eluting Devices Product and Services

Table 58. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Global Implantable Drug-Eluting Devices Sales by Manufacturer (2019-2021e) & (K Units)

Table 60. Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 61. Market Position of Manufacturers in Implantable Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 62. Global Implantable Drug-Eluting Devices Production Capacity by Company, (K Units): 2020 VS 2021

Table 63. Head Office and Implantable Drug-Eluting Devices Production Site of Key Manufacturer

Table 64. Implantable Drug-Eluting Devices New Entrant and Capacity Expansion Plans

Table 65. Implantable Drug-Eluting Devices Mergers & Acquisitions in the Past Five Years

Table 66. Global Implantable Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)

Table 67. Global Implantable Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)

Table 68. Global Implantable Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)

Table 69. Global Implantable Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)

Table 70. Global Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 71. Global Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 72. Global Implantable Drug-Eluting Devices Revenue by Type (2016-2021e) & (USD Million)

Table 73. Global Implantable Drug-Eluting Devices Revenue by Type (2021-2026) & (USD Million)

Table 74. Global Implantable Drug-Eluting Devices Price by Type (2016-2021e) & (USD/Unit)

Table 75. Global Implantable Drug-Eluting Devices Price by Type (2021-2026) & (USD/Unit)

Table 76. Global Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 77. Global Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 78. Global Implantable Drug-Eluting Devices Revenue by Application (2016-2021e) & (USD Million)

Table 79. Global Implantable Drug-Eluting Devices Revenue by Application (2021-2026) & (USD Million)

Table 80. Global Implantable Drug-Eluting Devices Price by Application (2016-2021e) & (USD/Unit)

Table 81. Global Implantable Drug-Eluting Devices Price by Application (2021-2026) & (USD/Unit)

Table 82. North America Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)

Table 83. North America Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)

Table 84. North America Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)

Table 85. North America Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)

Table 86. North America Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 87. North America Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 88. North America Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 89. North America Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 90. Europe Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)

Table 91. Europe Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)

Table 92. Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)

Table 93. Europe Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)

Table 94. Europe Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 95. Europe Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 96. Europe Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 97. Europe Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 98. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)

Table 99. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)

Table 100. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)

Table 101. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)

Table 102. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 103. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 104. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 105. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 106. South America Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)

Table 107. South America Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)

Table 108. South America Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)

Table 109. South America Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)

Table 110. South America Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 111. South America Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 112. South America Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 113. South America Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 114. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)

Table 115. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)

Table 116. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)

Table 117. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)

Table 118. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)

Table 119. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)

Table 120. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)

Table 121. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)

Table 122. Direct Channel Pros & Cons

Table 123. Indirect Channel Pros & Cons

Table 124. Implantable Drug-Eluting Devices Typical Distributors

Table 125. Implantable Drug-Eluting Devices Typical Customers

List of Figures

Figure 1. Implantable Drug-Eluting Devices Picture

Figure 2. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2020

Figure 3. Implantable Drug Infusion Pumps

Figure 4. Intraocular Drug-Eluting Devices

Figure 5. Contraceptive Drug-Eluting Devices

Figure 6. Drug-Eluting Stents

Figure 7. Others

Figure 8. Global Implantable Drug-Eluting Devices Sales Market Share by Application in 2020

Figure 9. Diabetes

Figure 10. Contraception

Figure 11. HIV/AIDS Prevention

Figure 12. Chronic Pain Management

Figure 13. Cardiovascular

Figure 14. Ophthalmology

Figure 15. Oncology

Figure 16. Others

Figure 17. Global Implantable Drug-Eluting Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 18. Global Implantable Drug-Eluting Devices Market Size and Forecast (2016-2026) & (USD Million)

Figure 19. Global Implantable Drug-Eluting Devices Sales (2016-2026) & (K Units)

Figure 20. Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)

Figure 21. Global Implantable Drug-Eluting Devices Production Capacity (2016-2026) & (K Units)

Figure 22. Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region: 2020 VS 2021

Figure 23. Implantable Drug-Eluting Devices Market Drivers

Figure 24. Implantable Drug-Eluting Devices Market Restraints

Figure 25. Implantable Drug-Eluting Devices Market Trends

Figure 26. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer in 2020

Figure 27. Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturer in 2020

Figure 28. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. Top 3 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020

Figure 30. Top 6 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020

Figure 31. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)

Figure 32. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2026)

Figure 33. North America Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)

Figure 34. Europe Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)

Figure 35. Asia-Pacific Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)

Figure 36. South America Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)

Figure 37. Middle East & Africa Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)

Figure 38. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)

Figure 39. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2026)

Figure 40. Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)

Figure 41. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 42. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2026)

Figure 43. Global Implantable Drug-Eluting Devices Price by Application (2016-2026) & (USD/Unit)

Figure 44. North America Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)

Figure 45. North America Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 46. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)

Figure 47. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)

Figure 48. United States Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)

Figure 52. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 53. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)

Figure 54. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)

Figure 55. Germany Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)

Figure 61. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)

Figure 63. Asia-Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2026)

Figure 64. China Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Japan Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Korea Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. India Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Southeast Asia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Australia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South America Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)

Figure 71. South America Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 72. South America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)

Figure 73. South America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)

Figure 77. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)

Figure 78. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)

Figure 79. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)

Figure 80. Turkey Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Egypt Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. South Africa Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Sales Channel: Direct Channel vs Indirect Channel

Figure 85. Methodology

Figure 86. Research Process and Data Source